NEW YORK (GenomeWeb) – Abbott said Wednesday that its fourth quarter diagnostic revenues grew 52 percent year over year on a reported basis and 7 percent year over year on a comparable operational basis to $1.91 billion from $1.26 billion in the year-ago period.

For the three months ended Dec. 31, 2017, Abbott reported worldwide revenues of $7.59 billion, up 42 percent from $5.33 billion a year ago, and topping the average Wall Street estimate of $7.39 billion. Sales increased 8 percent on a comparable operational basis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.